The Delhi High Court has refused to grant interim protection to pharmaceutical company Alkem Laboratories Ltd. in its trademark dispute against Prevego Healthcare & Research Pvt Ltd, allowing the latter to continue selling its multivitamin product under the brand name Multivein AZ while the litigation
The Delhi High Court has refused to grant relief to a beverage company seeking permission to sell its existing stock labeled with the term “ORS”, reinforcing the Food Safety and Standards Authority of India (FSSAI)’s stand against misleading labeling. The court observed that allowing the sale
The Delhi High Court has restrained Patanjali Ayurved Ltd. from broadcasting, printing, or publishing its recent ‘Dhoka’ Chyawanprash advertisement, following a petition filed by Dabur India Ltd., which alleged that the commercial disparaged and misrepresented its Chyawanprash brand Judge issued the interim order after Dabur argued
The Delhi High Court has dismissed a plea challenging the Food Safety and Standards Authority of India (FSSAI)’s directive banning the sale of beverages marketed under the guise of ‘ORS’ (Oral Rehydration Salts) formulations, reaffirming the regulator’s authority to act in the interest of public
Delhi CM Rekha Gupta Unveils Major Health Infrastructure Push Delhi Chief Minister Rekha Gupta announced on July 14 that her government is redeveloping seven long-pending ICU hospitals—initiated during the COVID‑19 pandemic—into fully equipped super‑specialty centres. During the inauguration of Yatharth Super Speciality Hospital in Model Town,
In a groundbreaking decision aimed at reinforcing justice and dignity for survivors of heinous crimes, the Delhi High Court has directed hospitals and nursing homes across the National Capital Territory to provide free medical treatment to victims of rape and acid attacks. The ruling underscores
Cure SMA Foundation of India, the largest parent-led patient advocacy organization for Spinal Muscular Atrophy (SMA) in the country, appreciates and acknowledges the positive strides made by the Government of India, the judiciary and the entire healthcare ecosystem towards addressing rare diseases in India. In
The Delhi High Court on Wednesday said if the Delhi government could not ensure that people will get both doses of COVAXIN within the stipulated time, then it should not have started so many vaccination centres with “much pomp and splendour”.Justice Rekha Palli issued notice
